Cargando…

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors

Detalles Bibliográficos
Autores principales:	Belczacka, Iwona, Latosinska, Agnieszka, Siwy, Justyna, Metzger, Jochen, Merseburger, Axel S., Mischak, Harald, Vlahou, Antonia, Frantzi, Maria, Jankowski, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718396/ https://www.ncbi.nlm.nih.gov/pubmed/31477787 http://dx.doi.org/10.1038/s41598-019-49304-9

Ejemplares similares

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2022)

CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019)

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

Urinary peptide panel for prognostic assessment of bladder cancer relapse
por: Krochmal, Magdalena, et al.
Publicado: (2019)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment
por: Lohia, Sonnal, et al.
Publicado: (2023)

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
por: Frantzi, Maria, et al.
Publicado: (2020)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis
por: Latosinska, Agnieszka, et al.
Publicado: (2015)

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020)

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
por: Frantzi, Maria, et al.
Publicado: (2023)

Urinary peptidomic profiles to address age-related disabilities: a prospective population study
por: Martens, Dries S, et al.
Publicado: (2021)

Urine peptidome analysis in cardiorenal syndrome reflects molecular processes
por: Petra, Eleni, et al.
Publicado: (2021)

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
por: Latosinska, Agnieszka, et al.
Publicado: (2017)

Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles
por: Siwy, Justyna, et al.
Publicado: (2012)

Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
por: Petra, Eleni, et al.
Publicado: (2022)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
por: Mokou, Marika, et al.
Publicado: (2020)

Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020)

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine
por: Filip, Szymon, et al.
Publicado: (2015)

Protein Interactome of Muscle Invasive Bladder Cancer
por: Bhat, Akshay, et al.
Publicado: (2015)

Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
por: Rouse, Rodney, et al.
Publicado: (2012)

BcCluster: A Bladder Cancer Database at the Molecular Level
por: Bhat, Akshay, et al.
Publicado: (2016)

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023)

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2020)

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
por: Bannaga, Ayman, et al.
Publicado: (2021)

Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure
por: He, Tianlin, et al.
Publicado: (2021)

A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
por: O’Connell, Shea P., et al.
Publicado: (2022)

Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
por: Frantzi, Maria, et al.
Publicado: (2017)

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
por: Chatziharalambous, Despina, et al.
Publicado: (2016)

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
por: Catanese, Lorenzo, et al.
Publicado: (2021)

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca(2+) signaling in T24M-based bladder cancer models
por: Frantzi, Maria, et al.
Publicado: (2016)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
por: Lygirou, Vasiliki, et al.
Publicado: (2018)

Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis—A multicentre study
por: Bannaga, Ayman S., et al.
Publicado: (2020)

Development of a MALDI MS‐based platform for early detection of acute kidney injury
por: Carrick, Emma, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0g1ht5abpsfbahnidkp98djk5d